Antibody Fragments Market Research Report and Forecast up to 2024 Antibody Fragments Market

Antibody Fragments Market - Global Industry
Analysis, Size, Share, Growth, Trends, and
Forecast 2016 - 2024
Whole antibodies have grabbed a significant share of the global sales revenue as
well as the volume of the biopharmaceuticals market. But with recent research and
development efforts, it has come to light that the whole or full-length antibodies
may always not be needed, or sometimes may not be desirable even for therapeutic
use. Antibody fragments come in the picture at this point. For example, anti-tumor
antibodies are larger in size and therefore can’t penetrate the tumor, thus affecting
their therapeutic value in tumor suppression. Antibodies are also inappropriate for
intracellular targeting sites because of their comparatively larger size. In this case,
antibody fragments having specific sequences for the target site is used. Antibody
fragments show enhanced penetration due to their smaller size. Antibody fragments
can bind at highly specific sites and they can be manufactured or designed without
the Fc region thus eliminating immunogenicity. Also, the antibody fragments have
low manufacturing cost, high yield in production and extended therapeutic uses.
View Report @ http://www.transparencymarketresearch.com/antibody-
fragments-market.html
Antibody Fragments Market: Segmentation
On the basis of product type, the antibody fragments market can be segmented
into,
F(ab) fragment
F(ab’)2 fragment
On the basis of disease indication, the antibody fragments market can be
segmented into,
Cancer
Immunodeficiencies
Others
On the basis of region, the antibody fragments market can be segmented into,
North America
Europe